Please login to the form below

Not currently logged in

Kantar Health appoints two senior researchers

Dr Theano Anasta and Svetlana Gogolina join research firm

Dr Theano Anasta and Svetlana Gogolina have joined market research firm Kantar Health as senior researchers in its UK team.

Dr Anasta (pictured right) joins from research company Holden Pearmain, where she was head of advanced methods and deputy managing director.

Other positions held prior to her time at Holden Pearmain include director of the marketing science centre at Research International UK.

Kantar-Svetlana-GogolinaKantar Theano Anasta

Gogolina's (pictured left) appointment is a return to Kantar after leaving the company in 2011 to become research director at Holden Pearmain.

She is now advanced methods consultant after serving as senior methodologist in her first spell.

Gogolina also spent seven months last year as partner in CLOUT.

“Theano and Svetlana bring extensive experience in designing complex studies and consulting with senior clients,” said Jim Needell, managing director of Kantar Health in the UK.

“They will help us deliver on our objectives of meeting our clients' growing needs and addressing their central business questions around managing product launch programmes and how to promote and measure their performance.”

29th January 2013

From: Sales, Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...